NKTR

Nektar Therapeutics

$77.04

-1.79 (-2.27%)

Volume:

239.103K ($18.42M)

#2358 Volume #1406 Dollar Volume

Market Capitalization:

$2.60B

#1810 Market Cap

Nektar Therapeutics Price Chart

Nektar Therapeutics Volume Chart

Nektar Therapeutics Market Segments

Regular Trading Hours

-1.34(-1.71%)

Open	$78.38
Close	$77.04
Low	$77.04
Low Change	-1.34 (-1.71%)
High	$79.25
High Change	+0.87 (+1.10%)
Range	$2.21
Volume	237.548K
Dollar Volume	$18.30M

Premarket

-0.56(-0.71%)

Open	$78.56
Close	$78.00
Low	$78.00
Low Change	-0.56 (-0.71%)
High	$78.56
High Change	+0.00 (+0.00%)
Range	$0.56
Volume	1.555K
Dollar Volume	$121.29K

After Hours Yesterday

-0.11(-0.14%)

Open	$78.72
Close	$78.61
Low	$78.55
Low Change	-0.17 (-0.22%)
High	$79.59
High Change	+0.87 (+1.11%)
Range	$1.04
Volume	9.78K
Dollar Volume	$768.80K

Regular Trading Hours Yesterday

-0.82(-1.03%)

Open	$79.65
Close	$78.83
Low	$76.61
Low Change	-3.04 (-3.82%)
High	$80.95
High Change	+1.30 (+1.63%)
Range	$4.34
Volume	1.355M
Dollar Volume	$106.80M

Premarket Yesterday

-1.20(-1.48%)

Open	$81.20
Close	$80.00
Low	$79.28
Low Change	-1.92 (-2.36%)
High	$81.75
High Change	+0.55 (+0.68%)
Range	$2.47
Volume	11.511K
Dollar Volume	$920.88K

Nektar Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$82.66
10 Day Moving Average (SMA10)	$83.85
20 Day Moving Average (SMA20)	$86.62
50 Day Moving Average (SMA50)	$78.38
100 Day Moving Average (SMA100)	$63.08
200 Day Moving Average (SMA200)	$55.15

Nektar Therapeutics Statistics

Average Volume (30 Days)	1.09M
P/E Ratio (Current)	-16.85
EPS (Current)	-$4.86
Dividend Yield	0.00%
Free Cash Flow	-$208.68M
Cash Ratio	0.28
Current Ratio	4.97
Quick Ratio	4.97
Debt to Equity	0.00
Enterprise Value	$2.75B
EV to EBITDA	-21.18
EV to Sales	49.75
Price to Book	30.76
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	50.03
Return on Assets	-0.59%
Return on Equity	-1.83%

Nektar Therapeutics Stock Splits

There has been 1 stock split for Nektar Therapeutics (NKTR). The reverse stock split occured on June 9, 2025 and reduced the outstanding shares at a ratio of 15:1.

Date	Type	Ratio
Jun 9, 2025	Reverse	15:1

Nektar Therapeutics Dividends

There have been no dividends for Nektar Therapeutics (NKTR).